“I’m not letting you leave my office with that on your back.”

Jordan remembers her dermatologist’s words at the appointment that changed her life. At just 20 years old, she was diagnosed with advanced, stage III melanoma. 

“Why me? I was too young to get skin cancer,” she remembers thinking. “I felt that I had done everything I could to limit my risk of skin cancer.”

But Jordan soon learned that while skin protection is important, skin cancer and melanoma can’t always be prevented.

Melanoma is the most serious and life-threatening type of skin cancer, but it is …

  • Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study1
  • Neovascular age-related macular degeneration accounts for 10% of age-related macular degeneration cases, but is responsible for 90% of AMD-related blindness2
  • With eight marketed biosimilar medicines globally and 15+ molecules in pipeline, Sandoz is investing in future of biosimilars for patients and healthcare systems